Local News: Seattle, WA 

 | 

Sign Up

 | 

Sign In

Teva Pharmaceutical Industries

Teva Pharmaceutical Industries News Editors

News Widget

Display the Teva Pharmaceutical Industries news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Teva Pharmaceutical Industries News

News on Teva Pharmaceutical Industries (Ticker: TEVA) continually updated from thousands of sources around the net.

13 hrs ago | Insider Monkey

Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Hedge Funds and...

Teva Pharmaceutical Industries Ltd was in 47 hedge funds' portfolio at the end of March.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry

Tue May 21, 2013

The Washington Post

Teva Bets on Reformulating Drugs as Investors Say - Show Me'

Teva Pharmaceutical Industries Ltd., which just two years ago was analysts' highest-rated stock among the world's 20 biggest drugmakers, is struggling to convince investors that a key part of its strategy will revive growth.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry, Health, Pain, New York, Sanford C. Bernstein, Bristol Myers Squibb

Mon May 20, 2013

Reuters

Israel seeks to rein in company tax breaks

Israel plans to amend a law granting companies tax breaks and grants to invest in the country as the government tries to close a widening budget deficit.

Comment?

Related Topix: Biotech

Seeking Alpha

A Broad Look At Teva's Pipeline

Teva Pharmaceutical is a widely followed Israel-based global pharmaceutical company; however, besides its popular Copaxone drug, I did not find a lot of studies about the other drug candidates in its pipeline.

Comment?

Related Topix: Biotech, Marketing, Food and Drug Administration

Sun May 19, 2013

Salt Lake Tribune

Confusion lingers in Utah over teen access to 'morning after pill'

In April, a Reagan-appointed federal judge issued an order to make the so-called "morning after" pill available over the counter to everyone regardless of their age.

Comment?

Related Topix: Healthcare Law, Law, Food and Drug Administration, Biotech

Wed May 15, 2013

Freshnews

Alexza Reports 2013 First Quarter Financial Results

Alexza Pharmaceuticals, Inc. today reported financial results for the fiscal quarter March 31, 2013.

Comment?

Related Topix: Alexza Pharmaceuticals, Startups, Biotech, Marketing, Cephalon, Mountain View, CA

Tue May 14, 2013

Seeking Alpha

Alexza Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript

Good afternoon, everyone, and welcome to the Alexza Pharmaceuticals 2013 First Quarter Financial Results Conference Call.

Comment?

Related Topix: Alexza Pharmaceuticals, Startups, Biotech

Bloomberg

Actavis Said to Have Spurned $15 Billion Offer From Mylan

Actavis Inc. rejected a cash-and-stock offer from fellow generic drugmaker Mylan Inc.

Comment?

Related Topix: Biotech, Medicine, Warner Chilcott, Healthcare Industry, Canonsburg, PA

BioSpace

Teva Pharmaceutical Industries Limited to Present at the Bank of...

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Teva Pharmaceutical Industries Ltd.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry, Las Vegas, NV

Daily Political

Teva Pharmaceutical Industries Ltd Stock Rating Reaffirmed by TheStreet

"Teva Pharmaceutical Industries has been reiterated by TheStreet Ratings as a hold with a ratings score of C+. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Healthcare Industry, Pharmaceuticals, Cephalon

Reuters

French competition body fines Sanofi in Plavix dispute

The French Competition Authority said on Tuesday it fined drugmaker Sanofi 40.6 million euros over what it called a smear campaign aimed at stifling generic competition to its blood thinner, Plavix.

Comment?

Related Topix: Medicine, Plavix, Clopidogrel (generic), Biotech

Mon May 13, 2013

BioSpace

The Week in Review: Sagent Pharmaceuticals, Inc. Buys Out China JV Partner for $25 Million

May 11, 2013 -- Sagent Pharma, a US generic injectible drugmaker, will pay $25 million to acquire its partner's 50% interest in a China manufacturing JV; ScinoPharm Taiwan and Coland Holdings formed a partnership to bring generic oncology drugs to mainland China; Zhejiang Huahai Pharma joined with Oncobiologics to develop and make biosimilars of ... (more)

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Sagent Pharmaceuticals, Amgen

Seeking Alpha

Teva: An Ideal Long-Term Pharma Stock

A study released by the IMS Institute for Health Informatics finds that per capita spending on medicines declined by $33 in 2012.

Comment?

Related Topix: Biotech, Marketing, Medicine, Multiple Sclerosis, Health, Eli Lilly, Healthcare Industry, Pfizer, Lipitor, Atorvastatin (generic)

Fri May 10, 2013

Bloomberg

Endo Loses Bid to Stop Sales of Generic Painkiller Rivals

Endo Health Solutions Inc. lost an effort to stop U.S. sales of generic versions of its extended-release painkiller that don't have tamper-resistant qualities.

Comment?

Related Topix: Biotech, Medicine, Endo Pharmaceuticals Holdings, Healthcare Industry, Food and Drug Administration, Impax Laboratories, Pharmaceuticals

AmericanBankingNews.com

Teva Pharmaceutical Industries Ltd Given Hold Rating at TheStreet

's stock had its "hold" rating restated by analysts at TheStreet in a research report issued to clients and investors on Friday, StockRatingsNetwork reports.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry, Cephalon

Jerusalem Post

19:07Lapid meets with Teva CEO over tax hikes for corporations

Finance Minister Yair Lapid met with Teva CEO Jeremy Levin on Friday to discuss Lapid's intentions to raise taxes for large corporations.

Comment?

Related Topix: Biotech, Israel, World News, Middle East,

Bloomberg

Delay of Access to Teva's - Morning-After' Pill Rejected by U.S. Judge

A federal judge rejected as "frivolous" a government request to delay the effect of his order giving girls of all ages access to the so-called morning after-pill. U.S. District Judge Edward R. Korman in Brooklyn, New York, refused today to put the ruling on hold while the government appeals his decision that the contraceptive doesn't require a ... (more)

Comment?

Related Topix: Healthcare Law, Law, Biotech, Brooklyn, NY, New York, NY, Food and Drug Administration

Jerusalem Post

Lapid meets with Teva CEO over tax hikes for corporations

Finance Minister Yair Lapid met with Teva CEO Jeremy Levin on Friday to discuss Lapid's intentions to raise taxes for large corporations.

Comment?

Related Topix: Biotech, Israel, World News, Middle East,

Wall St. Cheat Sheet

Cramer Says Sell Teva Pharmaceutical, But Buy SunTrust Banks and These 2 Stocks

Teva Pharmaceutical Industries Limited : Jim Cramer ranked this stock a Sell . Cramer previously ranked this stock a Sell on April 11, 2013.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry

Thu May 09, 2013

BayStreet.ca

Before the Bell Scans of MYL, TEVA, COV, VRX, and ZTS

StockCall.com Provides Stock Research on Mylan Inc., Teva Pharmaceutical Industries Ltd, Covidien plc, Valeant Pharmaceuticals International Inc., and Zoetis Inc.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry, Teva Pharmaceutical Industries, Valeant Pharmaceuticals International, Dey, Startups

Seattle Jobs